Spain Pharma Report September 2019
Building on the topics covered in our March 2019 report, this latest edition of Healthcare & Life Sciences Review Spain takes a closer look at the broader Spanish life sciences…
Egypt Pharma Report July 2019
Now enjoying a period of relative political stability and with a swathe of economic reforms in the pipeline, Egypt is once more becoming one of the most favourable investment destinations…
France Pharma Report June 2019
Following on from our March 2019 report, this latest issue of Healthcare & Life Sciences Review France takes a closer look at the wider French life sciences value chain and…
Korea Pharma Report May 2019
One of the indisputable economic success stories of the last half century, South Korea now stands as the world’s 11th largest economy, with a reputation for industrial excellence and innovation.…
InFocus: Rare Diseases Special Report
Long regarded as a neglected backwater within the drug discovery landscape and the preserve of only a handful of niche players, the rare disease space has been undergoing an extraordinary…
China Pharma Report April 2019
China is the country it is impossible to ignore and now accounts for a significant share of revenues for most major multinational pharmaceutical companies. Further, any firm sincerely committed to…
France Pharma Report March 2019
France – under the business-minded administration of President Emmanuel Macron – has been rapidly climbing investor priority rankings in recent years. This report examines the potential impact of a…
Spain Pharma Report March 2019
Having largely recovered from the impact of the global financial crisis and with several impressive fundamentals in place, Spain once again stands as one of Europe’s premier healthcare and life…
Turkey Pharma Report 2019
Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare system that is the envy of its neighbours – stands as one of the…
Algeria Pharma Report 2019
Topics covered in this report – which features the exclusive insights of government ministers, the heads of local pharma champions as well as multinational affiliate leaders – include the potential…
Malaysia Pharma Report 2018
Through exclusive interviews with the Malaysian Minister of Health as well as the head of the country’s regulatory body – the NPRA – this report examines emerging trends in Malaysian…
Hong Kong Pharma Report 2018
Despite its small population size, Hong Kong has long held a strategic interest for the healthcare and life sciences industries, whether as a testbed for innovative products and service delivery…